CA3091955A1 - Use of an oral bolus in the drying-off of dairy cattle - Google Patents
Use of an oral bolus in the drying-off of dairy cattle Download PDFInfo
- Publication number
- CA3091955A1 CA3091955A1 CA3091955A CA3091955A CA3091955A1 CA 3091955 A1 CA3091955 A1 CA 3091955A1 CA 3091955 A CA3091955 A CA 3091955A CA 3091955 A CA3091955 A CA 3091955A CA 3091955 A1 CA3091955 A1 CA 3091955A1
- Authority
- CA
- Canada
- Prior art keywords
- cattle
- bolus
- dry
- oral
- day
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/20—Inorganic substances, e.g. oligoelements
- A23K20/24—Compounds of alkaline earth metals, e.g. magnesium
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/02—Ammonia; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/20—Elemental chlorine; Inorganic compounds releasing chlorine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18173742.0 | 2018-05-23 | ||
| EP18173742 | 2018-05-23 | ||
| PCT/EP2019/062958 WO2019224149A1 (en) | 2018-05-23 | 2019-05-20 | Use of an oral bolus in the drying-off of dairy cattle |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3091955A1 true CA3091955A1 (en) | 2019-11-28 |
Family
ID=62235859
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3091955A Pending CA3091955A1 (en) | 2018-05-23 | 2019-05-20 | Use of an oral bolus in the drying-off of dairy cattle |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US10966921B2 (https=) |
| EP (1) | EP3668525A1 (https=) |
| JP (1) | JP7154384B2 (https=) |
| KR (1) | KR20210013202A (https=) |
| CN (1) | CN112153972A (https=) |
| AU (1) | AU2019272711B2 (https=) |
| BR (1) | BR112020023845A2 (https=) |
| CA (1) | CA3091955A1 (https=) |
| CL (1) | CL2020002843A1 (https=) |
| EA (1) | EA202092782A1 (https=) |
| MX (1) | MX2020012468A (https=) |
| UA (1) | UA129834C2 (https=) |
| WO (1) | WO2019224149A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2019224149A1 (en) * | 2018-05-23 | 2019-11-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of an oral bolus in the drying-off of dairy cattle |
| AR122366A1 (es) * | 2020-01-27 | 2022-09-07 | Ceva Sante Animale | Composición veterinaria para rumiantes lecheros para el tratamiento de la fiebre de la leche |
| UY39022A (es) * | 2020-01-27 | 2021-07-30 | Ceva Sante Animale | Composición veterinaria de anti-prolactina para rumiantes utilizada mediante administración intramamaria |
| HUE067496T2 (hu) | 2020-12-08 | 2024-10-28 | Ruminant Biotech Corp Ltd | Az állatoknak szánt anyagok bejuttatására szolgáló eszközök és módszerek fejlesztése |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5360823A (en) | 1993-11-02 | 1994-11-01 | Dawe's Inc. | Anionic salt formulation for milk fever |
| US5686125A (en) * | 1995-10-31 | 1997-11-11 | Kalmbach Feeds, Inc. | Granular anionic dry cow product |
| EP0943246A1 (en) | 1998-02-04 | 1999-09-22 | Suomen Rehu Oy | Complete fodder |
| US20020150633A1 (en) | 1999-03-31 | 2002-10-17 | Myron Danzer | Dry dairy cow supplement |
| US6521249B2 (en) * | 2001-03-22 | 2003-02-18 | Church & Dwight Co., Inc. | Feedstock for prepartum dairy cattle |
| US9497981B2 (en) | 2012-06-28 | 2016-11-22 | Phibro Animal Health Corporation | Medicated particulate animal feed supplements and methods of preparation |
| CN105029016B (zh) * | 2015-07-10 | 2019-03-15 | 石河子大学 | 围产前期奶牛专用糊化阴离子盐添加剂及其制备方法 |
| AU2018212566B2 (en) * | 2017-01-24 | 2022-11-24 | OmniGen Research, L.L.C. | Granulated feed supplement and methods for making and using |
| EP3764807A4 (en) * | 2018-03-14 | 2021-11-03 | Sustainable Community Development, LLC | PROBIOTIC AND FOOD ADDITIVE COMPOSITION |
| WO2019224149A1 (en) * | 2018-05-23 | 2019-11-28 | Boehringer Ingelheim Vetmedica Gmbh | Use of an oral bolus in the drying-off of dairy cattle |
| EP4064854A1 (en) | 2019-11-28 | 2022-10-05 | Boehringer Ingelheim Vetmedica GmbH | Use of sglt-2 inhibitors in the drying-off of non-human mammals |
| US11723919B2 (en) | 2020-06-12 | 2023-08-15 | Phibro Animal Health Corporation | Composition or combination comprising anionic dietary supplement and 25-hydroxy vitamin D |
-
2019
- 2019-05-20 WO PCT/EP2019/062958 patent/WO2019224149A1/en not_active Ceased
- 2019-05-20 UA UAA202008093A patent/UA129834C2/uk unknown
- 2019-05-20 KR KR1020207037286A patent/KR20210013202A/ko active Pending
- 2019-05-20 EP EP19724508.7A patent/EP3668525A1/en active Pending
- 2019-05-20 AU AU2019272711A patent/AU2019272711B2/en active Active
- 2019-05-20 CA CA3091955A patent/CA3091955A1/en active Pending
- 2019-05-20 BR BR112020023845-7A patent/BR112020023845A2/pt unknown
- 2019-05-20 JP JP2021508079A patent/JP7154384B2/ja active Active
- 2019-05-20 EA EA202092782A patent/EA202092782A1/ru unknown
- 2019-05-20 MX MX2020012468A patent/MX2020012468A/es unknown
- 2019-05-20 CN CN201980034405.8A patent/CN112153972A/zh active Pending
- 2019-05-20 US US16/416,428 patent/US10966921B2/en active Active
-
2020
- 2020-11-03 CL CL2020002843A patent/CL2020002843A1/es unknown
-
2021
- 2021-03-02 US US17/189,317 patent/US11890374B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| MX2020012468A (es) | 2021-02-09 |
| JP2021520417A (ja) | 2021-08-19 |
| US20190358154A1 (en) | 2019-11-28 |
| US20210177747A1 (en) | 2021-06-17 |
| JP7154384B2 (ja) | 2022-10-17 |
| US11890374B2 (en) | 2024-02-06 |
| KR20210013202A (ko) | 2021-02-03 |
| CL2020002843A1 (es) | 2021-04-23 |
| EP3668525A1 (en) | 2020-06-24 |
| BR112020023845A2 (pt) | 2021-04-13 |
| AU2019272711A1 (en) | 2020-11-19 |
| EA202092782A1 (ru) | 2021-04-19 |
| WO2019224149A1 (en) | 2019-11-28 |
| AU2019272711B2 (en) | 2024-10-03 |
| US10966921B2 (en) | 2021-04-06 |
| CN112153972A (zh) | 2020-12-29 |
| UA129834C2 (uk) | 2025-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11890374B2 (en) | Use of an oral bolus in the drying-off of dairy cattle | |
| Goff | Calcium and magnesium disorders | |
| Apelo et al. | Effects of reduced dietary protein and supplemental rumen-protected essential amino acids on the nitrogen efficiency of dairy cows | |
| Piantoni et al. | Evaluation of propylene glycol and glycerol infusions as treatments for ketosis in dairy cows | |
| Khorasani et al. | Influence of carbohydrate source and buffer on rumen fermentation characteristics, milk yield, and milk composition in late-lactation Holstein cows | |
| Rogers et al. | Production responses of dairy cows fed various amounts of rumen-protected methionine and lysine | |
| JP7441946B2 (ja) | 非ヒト動物の乾乳におけるsglt-2阻害剤の使用 | |
| Wu et al. | Calcium homeostasis, acid–base balance, and health status in periparturient Holstein cows fed diets with low cation–anion difference | |
| Aditya et al. | Intramammary infusion of Escherichia coli lipopolysaccharide negatively affects feed intake, chewing, and clinical variables, but some effects are stronger in cows experiencing subacute rumen acidosis | |
| Fleming et al. | Assessing bioavailability of ruminally protected methionine and lysine prototypes | |
| Maynou et al. | Effects of oral administration of acidogenic boluses at dry-off on performance and behavior of dairy cattle | |
| Goff | Transition cow immune function and interaction with metabolic diseases | |
| Imran et al. | Effect of microencapsulated butyric acid supplementation on growth performance, ileal digestibility of protein, duodenal morphology and immunity in broilers | |
| Giaccone et al. | Factors associated with milk urea concentrations in Girgentana goats | |
| Shen et al. | Transfer efficiency of melamine from feed to milk in lactating dairy cows fed with different doses of melamine | |
| Schwab et al. | Methionine supplementation options | |
| EA046153B1 (ru) | Применение перорального болюса при запуске молочного рогатого скота | |
| BR122024001079A2 (pt) | Uso de um bolus oral e métodos relacionados | |
| Olagaray et al. | Relative bioavailability of carnitine delivered by ruminal or abomasal infusion or by encapsulation in dairy cattle | |
| Bilgeçli et al. | The effects of supplementation of milk with sodium butyrate on calf performance, some blood parameters and fecal Escherichia coli (E. coli) presence1 | |
| Goff | Transition period management and nutrition problems-A few solutions | |
| Wood et al. | Effect of porcine plasma on growth and health of Holstein calves | |
| Wells | Using Plasma Amino Acid Profiles to Identify the Limiting Amino Acids in Lactating Dairy Cows | |
| Mammi | Strategies to improve transition dairy cows health and milk quality | |
| Richards | Assessing Bioavalability of Methionine Products and Their Effect on Milk Production and Body Composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20230517 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20241024 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20250203 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 6TH ANNIV.) - STANDARD Year of fee payment: 6 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250512 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-2-2-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250512 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT DETERMINED COMPLIANT Effective date: 20250527 |
|
| P13 | Application amended |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P13-X000 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: APPLICATION AMENDED Effective date: 20250527 |
|
| D15 | Examination report completed |
Free format text: ST27 STATUS EVENT CODE: A-2-2-D10-D15-D126 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: EXAMINER'S REPORT Effective date: 20250820 |
|
| P11 | Amendment of application requested |
Free format text: ST27 STATUS EVENT CODE: A-2-2-P10-P11-P100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: AMENDMENT RECEIVED - RESPONSE TO EXAMINER'S REQUISITION Effective date: 20251127 |